Aim: TPS concentrations were measured throughout normal pregnancy in matern
al serum (MS) and amniotic fluid (AF), in order to evaluate the usefulness
of TPS in the follow-up of pregnancy breast cancer patients. Patients and M
ethods: Following informed consent, 30 pregnant women during the 2nd trimes
ter, 28 during the 3rd and 26 at parturition were included in the study. Fo
r comparison 28 women in the Ist trimester and 28 healthy, non pregnant wom
en (controls) were also studied. Both MS and AF antigen values were measure
d by an enzyme immunoassay (BEKI Diagnostics). Results: Maternal serum TPS
concentrations increased significantly with gestational age (p<0.0001), bei
ng significantly higher in the 3rd trimester and during labor than those in
the controls (p<0.0001). Amniotic fluid TPS values were markedly elevated
compared with those in MS (p<0.0001, paired-t-test), declining significantl
y from the 2nd to the 3rd trimester (p<0.0015) and labor Both MS and AF TPS
values during labor depended on the mode of delivery, being higher in the
cases terminated by vaginal delivery, compared to those by elective cesarea
n section. Conclusion: Maternal serum TPS values are influenced significant
ly by pregnancy, and thus, this antigen, as tumor marker seems to be reliab
le only during early pregnancy.